FY 1996 Financial Report
This past fiscal year, which ran from June 1, 1995 to May 31, 1996, was MAPS' tenth and most successful ever in terms of both fund-raising and membership. I believe that at least part of this increasing …
LSD
A Dose/Response Human Pilot Study – Safety and Efficacy of MDMA in Modification of Physical Pain and Psychological Distress in End-Stage Cancer Patients
[This is not the current version of this protocol] Version 4.1 August 22, 1995 A DOSE/RESPONSE HUMAN PILOT STUDY – SAFETY AND EFFICACY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN MODIFICATION OF PHYSICAL …
FY 1993 Financial Report
At the beginning of this fiscal year, MAPS had about 350 members and $897 in the bank. By the end of the fiscal year, MAPS' membership had doubled to 707 and its balance was $46,066 (consisting of …
Documents from the DEA Scheduling Hearing of MDMA, 1984-1988
1.Introduction to the Legal Record of the DEA’s 1984-1988 MDMA Scheduling Hearings DEA Announcement of proposed scheduling of MDMA as a Schedule I Drug, Federal Register, July 27, 1984 2. Before …
LSD-Assisted Therapy
MAPS has completed the first double-blind, placebo-controlled study of the therapeutic use of LSD in human beings since the early 1970s. LSD (lysergic acid diethylamide) is a semi-synthetic compound first …
